Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wasmuth

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Medizinische Klinik (Munich, Germany : 1983)|December 20, 2003
[Genetic risk factors for hepatic fibrosis in chronic liver diseases]Hermann E Wasmuth, Frank Lammert, Siegfried Matern
Seminars in Liver Disease|July 29, 2010
Chemokines in liver inflammation and fibrosisHermann E Wasmuth, Frank Tacke, Christian Trautwein
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Chemokines as immune mediators of liver diseases related to the metabolic syndromeMarie-Luise Berres, Andreas Nellen, Hermann E Wasmuth
Expert Review of Clinical Pharmacology|November 26, 2011
Therapeutic potential of chemokine receptor antagonists for liver diseaseHacer Sahin, Marie-Luise Berres, Hermann E Wasmuth
Zeitschrift Fur Gastroenterologie|September 15, 2010
Cavitating mesenteric lymph node syndrome: a rare complication of refractory celiac diseaseE Sanson, N Gassler, C Trautwein, et al.
Biotechnology and Bioengineering|February 1, 1979
High-resolution flow-zonal centrifuge systemW J McAleer, W Hurni, E Wasmuth, et al.
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Chemokine-directed immune cell infiltration in acute and chronic liver diseaseKarlin Raja Karlmark, Hermann E Wasmuth, Christian Trautwein, et al.
Gastroenterology|May 8, 2001
Elevated levels of factor VIII:C as a possible risk factor for portal, splenic, and mesenteric vein thrombosisV M Brandenburg, R D Frank, H E Wasmuth, et al.
Gut|October 9, 2001
Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis CH E Wasmuth, C Stolte, A Geier, et al.
Journal of Clinical Gastroenterology|September 22, 2011
Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infectionMarie-Luise Berres, Beate Schlosser, Thomas Berg, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Medizinische Klinik (Munich, Germany : 1983)|December 20, 2003
[Genetic risk factors for hepatic fibrosis in chronic liver diseases]Hermann E Wasmuth, Frank Lammert, Siegfried Matern
Seminars in Liver Disease|July 29, 2010
Chemokines in liver inflammation and fibrosisHermann E Wasmuth, Frank Tacke, Christian Trautwein
Digestive Diseases (Basel, Switzerland)|May 13, 2010
Chemokines as immune mediators of liver diseases related to the metabolic syndromeMarie-Luise Berres, Andreas Nellen, Hermann E Wasmuth
Expert Review of Clinical Pharmacology|November 26, 2011
Therapeutic potential of chemokine receptor antagonists for liver diseaseHacer Sahin, Marie-Luise Berres, Hermann E Wasmuth
Zeitschrift Fur Gastroenterologie|September 15, 2010
Cavitating mesenteric lymph node syndrome: a rare complication of refractory celiac diseaseE Sanson, N Gassler, C Trautwein, et al.
Biotechnology and Bioengineering|February 1, 1979
High-resolution flow-zonal centrifuge systemW J McAleer, W Hurni, E Wasmuth, et al.
Expert Review of Gastroenterology & Hepatology|December 17, 2008
Chemokine-directed immune cell infiltration in acute and chronic liver diseaseKarlin Raja Karlmark, Hermann E Wasmuth, Christian Trautwein, et al.
Gastroenterology|May 8, 2001
Elevated levels of factor VIII:C as a possible risk factor for portal, splenic, and mesenteric vein thrombosisV M Brandenburg, R D Frank, H E Wasmuth, et al.
Gut|October 9, 2001
Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis CH E Wasmuth, C Stolte, A Geier, et al.
Journal of Clinical Gastroenterology|September 22, 2011
Soluble urokinase plasminogen activator receptor is associated with progressive liver fibrosis in hepatitis C infectionMarie-Luise Berres, Beate Schlosser, Thomas Berg, et al.
Pageof 11